All Articles

A routine filing reveals Natixis's sophisticated arbitrage strategy in the Just Group takeover, showing how big money navigates high-stakes M&A.

Adial Pharmaceuticals secures a crucial $2.86M, but the deal's structure raises serious questions about shareholder dilution versus fueling its promising AD04 drug.

Apolosign challenges the smart display market with a subscription-free ecosystem aimed at family organization. Is this a resilient strategy for long-term growth?

Argo's on-demand electric bus pilot in Brampton isn't just a new route; it's a test case for scaling smart transit and fueling the energy transition.

A landmark report tracking nearly 800 partnerships since 2016 reveals the high-stakes strategy shaping a new era of cures and personalized medicine.

Beyond virtual currency, NeoGames' 'RealFarm Craft' connects gamers with small farms, delivering real food as prizes and pioneering a new 'phygital' economy.

A new report reveals 632 cancer antibody deals since 2016. We analyze the multi-billion-dollar partnerships driving the next wave of cancer therapy.

Facing steep revenue decline from customer churn, Boardwalktech bets on aggressive cost cuts and an AI-powered platform pivot to survive. Is it enough?

Brookfield's latest preferred share issue is more than a simple refinance; it's a strategic move to cut long-term costs and fuel its global empire.

A new partnership with a Vietnamese agri-giant reveals Del Monte’s strategy to combat disease, climate change, and secure the future of our fruit supply.

Pharma firm SciSparc is betting big on a GERD device, but can it navigate global markets and shareholder dilution for a slice of a $3 billion industry?

Struggling automaker Chijet Motor's new $400M digital treasury dwarfs its market cap, signaling a risky pivot that redefines its entire corporate identity.

A Canadian miner’s upgrade to the OTCQX market is more than a financial move; it’s a key step to funding Mongolia’s next wave of essential tech metals.

Successful long-term toxicology data for HER-096 builds on Phase 1b success, solidifying its path to a pivotal Phase 2 trial for Parkinson's disease.

Primior launches its GAIA tokenization platform, aiming to open institutional U.S. real estate to global investors amid growing regulatory clarity.

A new burger joint in Oregon seems unrelated to medicine, but its data-driven expansion and customer tech offer a playbook for AI innovation in healthcare.

A NYC limo service is weaponizing child safety to outmaneuver Uber and Lyft. It's a strategic play in a market where peace of mind is the ultimate luxury.

Following pressure from activist Engine Capital, Civeo adds two new directors. Can they steer the hospitality giant toward renewed growth and profit?

As demographics shift, advocates push for innovative community care models and independent oversight to support Ontario's rapidly aging population.

A top Czech bank's deal with Camunda is more than a tech upgrade; it's a blueprint for efficiency that could reshape Central Europe's financial landscape.